Back to Journals » Biologics: Targets and Therapy » Volume 2 » Issue 1

Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer

Total article views   Abstract views HTML views PDF downloads Totals
4,892 Dovepress* 4,892 0+ 1,823 4,892
Totals 4,892 0 1,823 4,892
*Since 7 March 2008
+Since July 2016

View citations on Google Scholar